PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers, which delves into the mechanism of action of drugs and predicts the patient outcomes with close to 95% accuracy. Over the last 3 years PredxBio has empowered top 10 Pharma companies to accelerate discovery and revolutionize clinical trials across some of the highest mortality cancers and will impact the lives of more than 25 million cancer patients around the world.
